CLINICAL_TRIALS
withdrawal
· 2025-10-02
Clinical Trial Update: Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease [Phase 2]
Summary
A Phase 2 study evaluating Volenrelaxin in adults with chronic kidney disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Chronic Kidney Disease | Phase 2 | Status: WITHDRAWN